874 | TIME TOXICITY IN THE ERA OF BISPECIFIC ANTIBODY TREATMENT IN RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMA: CONCEPT ELICITATION WITH HEMATOLOGISTS AND PATIENT PERSPECTIVES
Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available